Zoetis is a global animal health company based in the United States. It was founded in 2013 as a spin-off from Pfizer, one of the leading pharmaceutical companies. With its headquarters in Parsippany, New Jersey, Zoetis has established itself as a significant player in the animal health industry.

Zoetis focuses on discovering, developing, manufacturing, and marketing veterinary drugs, vaccines, and diagnostic products for both livestock and companion animals. Their product portfolio includes a wide range of medications, vaccines, parasiticides, and other health products for the prevention and treatment of various animal diseases. They cater to various species, including cattle, poultry, swine, fish, dogs, cats, and horses.

The company has a strong global presence, operating in more than 100 countries worldwide. Zoetis has numerous subsidiaries, joint ventures, and partnerships. Notable subsidiaries include Fort Dodge Animal Health and PHARMAQ.

They have also collaborated with prominent organizations such as the Bill & Melinda Gates Foundation to tackle major animal health challenges in developing countries. Zoetis holds a significant market position in the animal health industry. It is the largest animal health company globally, with a market share of around 19%.

The company generates substantial global sales, with revenues surpassing $6 billion in recent years. Zoetis faces competition from other major players such as Merck Animal Health and Elanco Animal Health. In terms of growth and strategy, Zoetis has made several notable achievements.

In 2017, they acquired Nexvet Biopharma, a company focused on monoclonal antibody therapies for animals, to strengthen their biologic capabilities. They have also introduced innovative products like Simparica, a flea and tick preventive, and Improvest, an immunological castration technology for swine. As of the latest updates, Zoetis continues to expand its product portfolio and invest in research and development.

They are actively involved in the development of new vaccines and precision livestock farming technologies. The company remains a key player in the animal health industry, striving to improve animal welfare and contribute to the overall well-being of animals globally